- $3.69bn
- $5.02bn
- $4.94bn
- 44
- 63
- 93
- 74
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-Q | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Net Total Receivables | 220 | 222 | 85.8 | 263 | 84.3 |
Net Property, Plant And Equipment | 187 | 167 | 158 | 139 | 133 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Insurance Receivables | |||||
Other Long Term Assets | |||||
Deferred Policy Acquisition Costs | |||||
Total Other Assets | |||||
Total Assets | 12,989 | 14,342 | 14,917 | 13,314 | 12,743 |
Accrued Expenses | |||||
Policy Liabilities | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Funded Status | |||||
Total Liabilities | 9,017 | 9,779 | 10,909 | 10,643 | 10,238 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 3,972 | 4,563 | 4,008 | 2,671 | 2,505 |
Total Liabilities & Shareholders' Equity | 12,989 | 14,342 | 14,917 | 13,314 | 12,743 |
Total Common Shares Outstanding |